Document Detail


Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome.
MedLine Citation:
PMID:  18658135     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two groups of tau, 3R- and 4R-tau, are generated by alternative splicing of tau exon 10. Normal adult human brain expresses equal levels of them. Disruption of the physiological balance is a common feature of several tauopathies. Very early in their life, individuals with Down syndrome (DS) develop Alzheimer-type tau pathology, the molecular basis for which is not fully understood. Here, we demonstrate that Dyrk1A, a kinase encoded by a gene in the DS critical region, phosphorylates alternative splicing factor (ASF) at Ser-227, Ser-234, and Ser-238, driving it into nuclear speckles and preventing it from facilitating tau exon 10 inclusion. The increased dosage of Dyrk1A in DS brain due to trisomy of chromosome 21 correlates to an increase in 3R-tau level, which on abnormal hyperphosphorylation and aggregation of tau results in neurofibrillary degeneration. Imbalance of 3R- and 4R-tau in DS brain by Dyrk1A-induced dysregulation of alternative splicing factor-mediated alternative splicing of tau exon 10 represents a novel mechanism of neurofibrillary degeneration and may help explain early onset tauopathy in individuals with DS.
Authors:
Jianhua Shi; Tianyi Zhang; Chunlei Zhou; Muhammad Omar Chohan; Xiaosong Gu; Jerzy Wegiel; Jianhua Zhou; Yu-Wen Hwang; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong; Fei Liu
Related Documents :
2456565 - Amniotic fluid-afp in down syndrome and other chromosome abnormalities.
2653675 - Trisomy 9q3 syndrome: a case report and review of the literature.
13949185 - The extrarenal manifestations of hypernephroma.
20150875 - Edwards syndrome in a 6-year old girl.
21319515 - Internal jugular vein thrombosis as paraneoplastic syndrome of primary ovarian non-hodg...
20374515 - Marathon of eponyms: 10 jadassohn-lewandowsky syndrome (pachyonychia congenita).
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2008-07-24
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  283     ISSN:  0021-9258     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-10-13     Completed Date:  2008-11-25     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  28660-9     Citation Subset:  IM    
Affiliation:
Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, P. R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alternative Splicing
Animals
Brain / embryology,  metabolism
COS Cells
Cell Line, Tumor
Cercopithecus aethiops
Down Syndrome / metabolism*
Hela Cells
Humans
Models, Biological
Neurodegenerative Diseases / pathology
Protein-Serine-Threonine Kinases / metabolism*
Protein-Tyrosine Kinases / metabolism*
Rats
Serine / chemistry
tau Proteins / chemistry*
Grant Support
ID/Acronym/Agency:
AG019158/AG/NIA NIH HHS; AG027429/AG/NIA NIH HHS; HD43960/HD/NICHD NIH HHS; R01 AG019158-08/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/MAPT protein, human; 0/tau Proteins; 56-45-1/Serine; EC 2.7.1.-/Dyrk kinase; EC 2.7.10.1/Protein-Tyrosine Kinases; EC 2.7.11.1/Protein-Serine-Threonine Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation.
Next Document:  Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust co...